Search

Your search keyword '"Yao, Lili"' showing total 695 results

Search Constraints

Start Over You searched for: Author "Yao, Lili" Remove constraint Author: "Yao, Lili"
695 results on '"Yao, Lili"'

Search Results

52. Fish species mislabelling in China: evidence from a survey of frozen, dried, and surimi-based fish products marketed as cod-related species.

53. BF.7: a new Omicron subvariant characterized by rapid transmission

67. Improving Collaborative Filtering with Long-Short Interest Model

70. EEST: Entity-Driven Exploratory Search for Twitter

73. Abstract 477: Discovery of RGT-018: A potent, selective and orally bioavailable SOS1 inhibitor for mutant KRAS-driven cancers

74. Data from Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271

75. Supplementary Data from Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271

78. Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug Design

79. Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study

80. Compensating Effects Between Climate and Underlying Characteristics on Watershed Water Loss

82. Repeater Analysis for Combining Information from Different Assessments

85. Closed‐tube visual detection of Atlantic cod (Gadus morhua) using self‐quenched primer coupled with a designed loop‐mediated isothermal amplification vessel.

86. Target‐mediated suppression of rolling circle amplification for label‐free detection of aflatoxin B1.

87. Target‐mediated suppression of rolling circle amplification for label‐free detection of aflatoxin B1.

88. KEYNOTE-630: Phase 3 Study of Adjuvant Pembrolizumab in High-Risk Locally Advanced (LA) Cutaneous Squamous Cell Carcinoma (cSCC)

91. CTIM-03. PEMBROLIZUMAB MONOTHERAPY FOR MICROSATELLITE INSTABILITY-HIGH (MSI-H) OR MISMATCH REPAIR DEFICIENT (DMMR) RECURRENT GLIOMAS: RESULTS FROM THE MULTICOHORT PHASE 2 KEYNOTE-158 STUDY

98. Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study

99. Improving the valence self-reversible conversion of cerium nanoparticles on titanium implants by lanthanum doping to enhance ROS elimination and osteogenesis

Catalog

Books, media, physical & digital resources